Novel Cell Line Approaches for Extremely Rapid Production of Antibodies for Human Clinical Trials and Other Purposes: Covid-19 and Beyond
A Cell Culture Engineering (CCE) Webinar
Bringing the CCE community together prior to CCE 2023
Wednesday, April 27, 2022
12 noon – 3 pm EDT
Program
12:00 – 12:05 pm
Introduction by the Webinar Chairs
Matt Croughan
Gene Schaefer
12:05 – 12:30 pm
“Unprecedented speed in developing REGEN-COV©: The power of Regeneron’s Rapid Response Ab development platform”
Darya Burakov & Gang Chen (Regeneron)
12:30 – 12:55 pm
“Extremely rapid cell line development for accelerated clinical approvals of Covid-19 antibodies”
Kee Wee Tan, Zheng Zhang, Ji Chen, Junghao Wang, Qiao Gao, Fenglin Wang, Shurong Xu, Jiansheng Wu, Jill Cai, Weichang Zhou (WuXi)
12:55 – 1:20 pm
“Shortening the clinical development timeline with a novel method for generating stable, high producing cell pools”
Greg Bleck (Catalent)
1:20 – 1:25 pm Break
1:25 – 1:50 pm
“Use of pools for extremely rapid production of antibodies for clinical trials”
Sarah Dunn & Michael Handlogten (Astra Zeneca)
1:50 – 2:15 pm
“Power of platform to accelerate therapies beyond a pandemic”
Ronan Kelly & Chris Frye (Lilly)
2:15 – 2:55 pm
Panel Discussion
Speakers and Sarah Arden (GSK), Brian Kelley (Vir) and Chris Frye (Lilly)
2:55 – 3:00 pm
Closing Remarks by Webinar Chairs